Epilepsy Monitoring Devices Market Size & Share, by Product (Conventional, Wearable, Implantable Devices); Technology (Vagus Nerve, Responsive Neuro, Deep Brain Stimulations, Accelerometry); Epilepsy Detection & Prediction Devices (Electroencephalogram (EEG), Intracranial EEG, Surface Electromyography, Electrodermal Activity, Electrocardiography); End-user (Hospitals & Clinics, Home Care Settings) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4375
  • Published Date: Mar 09, 2023
  • Report Format: PDF, PPT

Companies Dominating the Epilepsy Monitoring Devices Landscape

    • Natus Medical Incorporated
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Compumedics Limited
    • Empatica Inc.
    • Magstim, Inc.
    • Nihon Kohden Corporation
    • Medtronic Plc
    • Boston Scientific Corporation
    • Masimo Corporation
    • Drägerwerk AG & Co. KGaA
    • Abbott Laboratories

Browse Key Market Insights with Data Illustration:


In The News

  • Empatica Inc. has obtained Food and Drug Administration (FDA) approval for Embrace2, which employs AI (advanced machine learning) in a wristwatch. It uses Electrodermal Activity (EDA), a signal that stress researchers employ to measure physiological changes associated with sympathetic nervous system activity.

  • Magstim, Inc. developed ‘Horizon 3.0’, which has received clearance from the FDA (Food and Drug Administration) as a transcranial magnetic stimulation platform. It offers improved workflows with guided transcranial magnetic stimulation (TMS), and analytics for the therapeutic context.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4375
  • Published Date: Mar 09, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

An increase in brain Injuries and a rising geriatric population are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

Exorbitant price of advanced epilepsy monitoring equipment and low awareness among people in low and middle-income countries for these medical devices are estimated to be the growth hindering factors for the market expansion.

The market in the Europe region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Compumedics Limited, Empatica Inc., Magstim, Inc., Nihon Kohden Corporation, Medtronic Plc, Boston Scientific Corporation, Masimo Corporation, Drägerwerk AG & Co. KGaA, Abbott Laboratories, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, technology, epilepsy detection & prediction devices, end user, and by region.

The deep brain stimulations segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying